Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

GMonte Rosa Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
G

Monte Rosa Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $8.97M. Net result −$43.4M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $8.97M. Running result $8.97M. Revenue: $8.97M.
  • Cost of revenue: $0. Running result $8.97M.
  • Gross profit: $8.97M. Running result $8.97M.
  • Research and development: −$47.96M. Running result −$39M.
  • General and administrative: −$10.13M. Running result −$49.13M.
  • Operating income: −$49.13M. Running result −$49.13M.
  • Other income: $5.94M. Running result −$43.19M.
  • Pre-tax loss: −$43.19M. Running result −$43.19M.
  • Income tax expense: −$208K. Running result −$43.4M.
  • Net loss: −$43.4M. Running result −$43.4M.